Toth Financial Advisory’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.42K Buy
+17
New +$2.58K ﹤0.01% 766
2023
Q4
– Sell
-54
Closed -$5.5K – 775
2023
Q3
$5.5K Buy
+54
New +$5.48K ﹤0.01% 514

Other funds holding NVS

Toth Financial Advisory's NVS Position: Q3 2026 in Review

Toth Financial Advisory opened a new position in Novartis (NVS) in Q3 2026: 17 shares worth $2.42K. The stake represents ﹤0.01% of the portfolio and ranks #766 among its holdings. This is a return to the name: Toth Financial Advisory previously reported a position in NVS as recently as Q3 2023.

Toth Financial Advisory first reported a position in NVS in Q3 2023 and has held it in 2 quarters since. The position peaked at $5.5K in Q3 2023. 83 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Toth Financial Advisory held 17 shares of Novartis worth $2.42K as of Q3 2026.
  • Novartis was a new Toth Financial Advisory position in Q3 2026.
  • Novartis made up ﹤0.01% of Toth Financial Advisory's portfolio in Q3 2026, its #766 holding.
  • Toth Financial Advisory first reported a position in Novartis in Q3 2023 and has held it in 2 quarters since.
  • Toth Financial Advisory's Novartis position peaked at $5.5K in Q3 2023.
  • 83 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Toth Financial Advisory's 13F filing for Q3 2026, filed 8 Oct 2026.